Literature DB >> 21340731

Scutellarin blocks sodium current in freshly isolated mouse hippocampal CA1 neurons.

Guangqin Zhang1, Suhua Qiu, Heming Wei.   

Abstract

Scutellarin (Scu), the main bioactive component of Erilgeron breviscapus, protects the brain against ischemic damages. To explore the therapeutic mechanism of Scu, we investigated the impact of Scu on sodium current (I(Na)) of freshly isolated mouse hippocampal CA1 neurons using the whole-cell patch clamp technique. Results showed that Scu inhibited I(Na) in concentration- and holding potential-dependent manners. At 50 μM, Scu markedly shifted the steady state inactivation curve of I (Na) towards a more negative potential, slowed down the recovery of I(Na) from inactivation state, and elicited a frequency-dependent block of I (Na). The shape of the current-voltage (I-V) curve and the steady state activation curve of I(Na) were unaffected by Scu treatment. These findings suggest that Scu is capable of inhibiting I(Na) in neurons through predominantly affecting the inactivated state of I(Na). Inhibition of Na(+) channels provides a novel pharmacological basis for the anti-ischemic application of Scu.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21340731     DOI: 10.1007/s11064-011-0426-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat.

Authors:  P A Boxer; J J Cordon; M E Mann; L C Rodolosi; M G Vartanian; D M Rock; C P Taylor; F W Marcoux
Journal:  Stroke       Date:  1990-11       Impact factor: 7.914

Review 2.  Neuroprotection by Na+ channel blockade.

Authors:  Hugh C Hemmings
Journal:  J Neurosurg Anesthesiol       Date:  2004-01       Impact factor: 3.956

Review 3.  Sodium channel blockers.

Authors:  Donald J Kyle; Victor I Ilyin
Journal:  J Med Chem       Date:  2007-05-10       Impact factor: 7.446

4.  The use-dependent sodium channel blocker mexiletine is neuroprotective against global ischemic injury.

Authors:  K E Hewitt; P K Stys; H J Lesiuk
Journal:  Brain Res       Date:  2001-04-20       Impact factor: 3.252

Review 5.  Sodium channel blockers in neuropathic pain.

Authors:  Eija Kalso
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

6.  Increased intracellular Na+ augments mobilization of Ca2+ from SR in vascular smooth muscle cells.

Authors:  M L Borin; R M Tribe; M P Blaustein
Journal:  Am J Physiol       Date:  1994-01

7.  Neuroprotective effects of tetrodotoxin as a Na+ channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia.

Authors:  P G Lysko; C L Webb; T L Yue; J L Gu; G Feuerstein
Journal:  Stroke       Date:  1994-12       Impact factor: 7.914

8.  Cerebroprotective effect of lamotrigine after focal ischemia in rats.

Authors:  S E Smith; B S Meldrum
Journal:  Stroke       Date:  1995-01       Impact factor: 7.914

9.  Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones.

Authors:  C C Kuo; L Lu
Journal:  Br J Pharmacol       Date:  1997-07       Impact factor: 8.739

10.  Genistein inhibits voltage-gated sodium currents in SCG neurons through protein tyrosine kinase-dependent and kinase-independent mechanisms.

Authors:  Zhanfeng Jia; Yueqin Jia; Boyi Liu; Zhiying Zhao; Qingzhong Jia; Huiling Liang; Hailin Zhang
Journal:  Pflugers Arch       Date:  2008-01-29       Impact factor: 3.657

View more
  2 in total

Review 1.  Scutellarin as a Potential Therapeutic Agent for Microglia-Mediated Neuroinflammation in Cerebral Ischemia.

Authors:  Yun Yuan; Ming Fang; Chun-Yun Wu; Eng-Ang Ling
Journal:  Neuromolecular Med       Date:  2016-04-21       Impact factor: 3.843

2.  Functional Recovery after Scutellarin Treatment in Transient Cerebral Ischemic Rats: A Pilot Study with (18) F-Fluorodeoxyglucose MicroPET.

Authors:  Jin-Hui Li; Jing Lu; Hong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-02       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.